VIRACEPT (R) (nelfinavir mesylate) Tablets, 625 mg, 120-count bottle, Rx only, Manufactured by: A...

FDA Drug Recall #D-1443-2014 — Class III — July 8, 2014

Recall Summary

Recall Number D-1443-2014
Classification Class III — Low risk
Date Initiated July 8, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Pfizer Inc.
Location New York, NY
Product Type Drugs
Quantity 1200 tablets

Product Description

VIRACEPT (R) (nelfinavir mesylate) Tablets, 625 mg, 120-count bottle, Rx only, Manufactured by: Agouron Pharmaceuticals, Inc. A Pfizer Company, Distributed by: ViV Healthcare Company, Research Triangle Park, NC 27709 NDC 63010-027-70

Reason for Recall

Labeling: Incorrect or missing lot and or Exp Date: The bottles were labeled with an incorrect expiry date 11/2016. The correct expiry date is 09/2016.

Distribution Pattern

Nationwide and Puerto Rico

Lot / Code Information

Lot H45241, exp. 11/16

Other Recalls from Pfizer Inc.

Recall # Classification Product Date
D-0545-2025 Class II Bicillin L-A (penicillin G benzathine injectabl... Jul 10, 2025
D-0544-2025 Class II Bicillin L-A (penicllin G benzathine injectable... Jul 10, 2025
D-0489-2025 Class II DOBUTamine Injection, USP, 250 mg/20 mL (12.5 m... May 28, 2025
D-0565-2024 Class II Labetalol Hydrochloride Injection, USP, 20 mg/4... May 20, 2024
D-0564-2024 Class II Buprenorphine Hydrochloride Injection, 0.3 mg b... May 20, 2024

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.